| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | NeuClone is a biotechnology company developing and commercialising high quality biosimilars. The company is focused on creating a deep pipeline of clinically identical biosimilars at significantly reduced prices for entry into both new and established markets. |
| Category: | Health & biotech |
| URL: | http://www.neuclone.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | Australian Technology Park, National Innovation Centre, 4 Cornwallis Street Eveleigh, Sydney, NSW, 2015 AUSTRALIA |
| State: | New South Wales |
| Overseas Operations: | No |
| Twitter: | [twitter-timeline username=”neuclone_“] |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/neuclone-pty-ltd |
| Founders: |
No items found
|
| Awards won: | |
